Pages that link to "Q33299610"

The following pages link to A rapid and sensitive bioassay to measure bone morphogenetic protein activity (Q33299610):

Displaying 47 items.

• Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation (Q24300318) (← links)
• WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity (Q24305801) (← links)
• Agrin binds BMP2, BMP4 and TGFbeta1 (Q24315763) (← links)
• Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells (Q24337548) (← links)
• Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways (Q24621990) (← links)
• WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity (Q24635850) (← links)
• Potential roles of BMP9 in liver fibrosis (Q26998823) (← links)
• Abnormal Activation of BMP Signaling Causes Myopathy in Fbn2 Null Mice (Q27310854) (← links)
• Multi-lineage MSC differentiation via engineered morphogen fields. (Q27327212) (← links)
• Extracellular matrix protein anosmin promotes neural crest formation and regulates FGF, BMP, and WNT activities (Q28273253) (← links)
• BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells (Q28296361) (← links)
• BRITER: a BMP responsive osteoblast reporter cell line (Q28483777) (← links)
• A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum (Q33419686) (← links)
• sFRP2 Suppression of Bone Morphogenic Protein (BMP) and Wnt Signaling Mediates Mesenchymal Stem Cell (MSC) Self-renewal Promoting Engraftment and Myocardial Repair (Q34285194) (← links)
• Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants (Q34313807) (← links)
• Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome (Q34341127) (← links)
• In vivo ectopic bone formation by devitalized mineralized stem cell carriers produced under mineralizing culture condition (Q34579472) (← links)
• Coordinated regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by endogenous bone morphogenetic proteins. (Q35108879) (← links)
• Initiation of BMP2 signaling in domains on the plasma membrane. (Q35846419) (← links)
• Synergistic interaction between the fibroblast growth factor and bone morphogenetic protein signaling pathways in lens cells (Q36063693) (← links)
• Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway (Q36179224) (← links)
• Mechanical strain promotes osteoblast ECM formation and improves its osteoinductive potential (Q36412560) (← links)
• Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice. (Q36625078) (← links)
• Cathepsin-Mediated Alterations in TGFß-Related Signaling Underlie Disrupted Cartilage and Bone Maturation Associated With Impaired Lysosomal Targeting (Q36730987) (← links)
• A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing (Q36976161) (← links)
• FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. (Q37052894) (← links)
• Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors (Q37138985) (← links)
• BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein (Q37179550) (← links)
• Development of an ALK2-biased BMP type I receptor kinase inhibitor (Q37513815) (← links)
• MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells (Q37592108) (← links)
• Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases (Q38199567) (← links)
• The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling (Q38809268) (← links)
• Fibrillin-1 Regulates Skeletal Stem Cell Differentiation by Modulating TGFβ Activity Within the Marrow Niche. (Q38851482) (← links)
• A modular versatile chip carrier for high-throughput screening of cell-biomaterial interactions (Q39244832) (← links)
• BMP4 promotes prostate tumor growth in bone through osteogenesis (Q39525268) (← links)
• Coating of titanium implant materials with thin polymeric films for binding the signaling protein BMP2. (Q39631313) (← links)
• In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. (Q42242654) (← links)
• Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophies (Q45884269) (← links)
• Identification of direct negative crosstalk between the SLIT2 and Bone Morphogenetic Protein-Gremlin signaling pathways (Q47215853) (← links)
• Variable signaling activity by FOP ACVR1 mutations (Q47447929) (← links)
• Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology. (Q47705980) (← links)
• Enhancement of osteogenic gene expression for the differentiation of human periosteal derived cells (Q84565379) (← links)
• Immunogenicity of osteogenic protein 1: results from a prospective, randomized, controlled, multicenter pivotal study of uninstrumented lumbar posterolateral fusion (Q85120106) (← links)
• Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective (Q86706441) (← links)
• Spatiotemporal material functionalization via competitive supramolecular complexation of avidin and biotin analogs (Q90287929) (← links)
• Future treatments for hereditary hemorrhagic telangiectasia (Q92476000) (← links)
• The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease (Q96609644) (← links)